Literature DB >> 12000612

Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria.

P A Lambert1.   

Abstract

Gram-positive bacteria possess a permeable cell wall that usually does not restrict the penetration of antimicrobials. However, resistance due to restricted penetration can occur, as illustrated by vancomycin-intermediate resistant Staphylococcus aureus strains (VISA) which produce a markedly thickened cell wall. Alterations in these strains include increased amounts of nonamidated glutamine residues in the peptidoglycan and it is suggested that the resistance mechanism involves 'affinity trapping' of vancomycin in the thickened cell wall. VISA strains have reduced doubling times, lower sensitivity to lysostaphin and reduced autolytic activity, which may reflect changes in the D-alanyl ester content of the wall and membrane teichoic acids. Mycobacterial cell walls have a high lipid content, which is assumed to act as a major barrier to the penetration of antimicrobial agents. Relatively hydrophobic antibiotics such as rifampicin and fluoroquinolones may be able to cross the cell wall by diffusion through the hydrophobic bilayer composed of long chain length mycolic acids and glycolipids. Hydrophilic antibiotics and nutrients cannot diffuse across this layer and are thought to use porin channels which have been reported in many species of mycobacteria. The occurrence of porins in a lipid bilayer supports the view that the mycobacterial wall has an outer membrane analogous to that of Gram-negative bacteria. However, mycobacterial porins are much less abundant than in the Gram-negative outer membrane and allow only low rates of uptake for small hydrophilic nutrients and antibiotics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000612

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  76 in total

Review 1.  Cell Walls and the Convergent Evolution of the Viral Envelope.

Authors:  Jan P Buchmann; Edward C Holmes
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

2.  Streptanoate, a new anticancer butanoate from Streptomyces sp. DC3.

Authors:  Saisattha Noomnual; Nopporn Thasana; Pareenart Sungkeeree; Skorn Mongkolsuk; Suvit Loprasert
Journal:  J Antibiot (Tokyo)       Date:  2015-09-16       Impact factor: 2.649

3.  Effects of Formulation on Microbicide Potency and Mitigation of the Development of Bacterial Insusceptibility.

Authors:  Nicola L Cowley; Sarah Forbes; Alejandro Amézquita; Peter McClure; Gavin J Humphreys; Andrew J McBain
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

4.  Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.

Authors:  Peter A Smith; Tucker C Roberts; Floyd E Romesberg
Journal:  Chem Biol       Date:  2010-11-24

5.  Tools for characterizing bacterial protein synthesis inhibitors.

Authors:  Cédric Orelle; Skylar Carlson; Bindiya Kaushal; Mashal M Almutairi; Haipeng Liu; Anna Ochabowicz; Selwyn Quan; Van Cuong Pham; Catherine L Squires; Brian T Murphy; Alexander S Mankin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert Liddington
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

7.  Surface hydrolysis of sphingomyelin by the outer membrane protein Rv0888 supports replication of Mycobacterium tuberculosis in macrophages.

Authors:  Alexander Speer; Jim Sun; Olga Danilchanka; Virginia Meikle; Jennifer L Rowland; Kerstin Walter; Bradford R Buck; Mikhail Pavlenok; Christoph Hölscher; Sabine Ehrt; Michael Niederweis
Journal:  Mol Microbiol       Date:  2015-07-04       Impact factor: 3.501

8.  Increased Vancomycin Susceptibility in Mycobacteria: a New Approach To Identify Synergistic Activity against Multidrug-Resistant Mycobacteria.

Authors:  Karine Soetaert; Céline Rens; Xiao-Ming Wang; Jacqueline De Bruyn; Marie-Antoinette Lanéelle; Françoise Laval; Anne Lemassu; Mamadou Daffé; Pablo Bifani; Véronique Fontaine; Philippe Lefèvre
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

Review 9.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

10.  Understanding the dark and light-enhanced bactericidal action of cationic conjugated polyelectrolytes and oligomers.

Authors:  Ying Wang; Stephen D Jett; John Crum; Kirk S Schanze; Eva Y Chi; David G Whitten
Journal:  Langmuir       Date:  2013-01-03       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.